Felcisetrag

DB12725InvestigationalSmall molecule

Felcisetrag (TD-8954) has been used in trials studying the treatment of Enteral Feeding Intolerance and Gastrointestinal Motility Disorder.

Chemical structure of Felcisetrag
Mechanism
Curator reviewed
Formula / weight
C25H37N5O3 · 455.603 g/mol (avg)
Code names
TAK-954 · TD-8954 · THRX-149699

Resolves to

Compound
UNII35F0Y2W16QCAS916075-84-8ChEMBLCHEMBL2402904PubChem11961293
Structure
InChIKeyMZOITCJKGUIQEI-UHFFFAOYSA-NSMILESCOC(=O)N1CCC(CN2CCC(CNC(=O)C3=C4NC(=NC4=CC=C3)C(C)C)CC2)CC1
Targets
Q13639HTR4

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
707Drug interactionsStructured to mechanism, not free text
Sign in
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Felcisetrag, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In